지원사업
학술연구/단체지원/교육 등 연구자 활동을 지속하도록 DBpia가 지원하고 있어요.
커뮤니티
연구자들이 자신의 연구와 전문성을 널리 알리고, 새로운 협력의 기회를 만들 수 있는 네트워킹 공간이에요.
논문 기본 정보
- 자료유형
- 학술저널
- 저자정보
- 발행연도
- 2014.1
- 수록면
- 1 - 8 (8page)
이용수
초록· 키워드
오류제보하기
Europe has taken many political actions since 1999 to better control antimicrobial resistance and use, including two European Council Recommendations and actions taken by numerous European Union (EU) presidencies. These presidencies triggered many public health and research actions in the EU. Europe developed several very successful surveillance programmes on antimicrobial resistance and antimicrobial use, both currently coordinated by the European Centre for Disease Prevention and Control (ECDC). These surveillance programmes were able to identify emerging problems of antibiotic resistance and targets for quality improvement of antimicrobial use; they also conducted impact assessments of campaigns to reduce antibiotic use and increase hand hygiene. The public antibiotic awareness campaigns were very successful in reducing antibiotic use and resistance in countries like Belgium and France. The successes of these campaigns inspired ECDC to launch an annual European Antibiotic Awareness Day on November 18, 2008. The hand hygiene campaigns resulted in a dramatic decrease of MRSA infections in many EU Member States. However, ESBL- producing Gram-negative bacteria and Carbapenem- resistant Enterobacteriaceae and non-fermenters are increasing in most EU countries. Finally, the EU is investing hundreds of millions of EUROs in a Public Private Partnership (PPP), called the Innovative Medicines Initiative (IMI). An important initiative of IMI is the launch of the Combating Antibiotic Resistance NewDrugs4BadBugs programme. The goal of this new research programme is to create an innovative and collaborative PPP-based approach that will positively impact all aspects of the antimicrobial resistance issue, from the discovery of novel products to Phase 1-3 clinical trials. (Ann Clin Microbiol 2014;17:1-8)
목차
등록된 정보가 없습니다.
참고문헌 (25)
참고문헌 신청
/ / European Surveillance of Antimicrobial Consumption: the ESAC programme
Adriaenssens N / 2010 / European Surveillance of Antimicrobial Consumption (ESAC): outpatient systemic antimycotic and antifungal use in Europe / J Antimicrob Chemother 65 :
Amadeo B / 2010 / ESAC III Hospital Care Subproject Group. European Surveillance of Antibiotic Consumption (ESAC) point prevalence survey 2008: paediatric antimicrobial pres
Bronzwaer SL / 2001 / International surveillance of antimicrobial resistance in Europe: now we also need to monitor antibiotic use / Euro Surveill 6 : 1 ~ 2
Coenen S / 2006 / European Surveillance of Antimicrobial Consumption (ESAC): outpatient cephalosporin use in Europe / J Antimicrob Chemother 58 : 413 ~ 417
Adriaenssens N / 2010 / European Surveillance of Antimicrobial Consumption (ESAC): outpatient systemic antimycotic and antifungal use in Europe / J Antimicrob Chemother 65 :
Amadeo B / 2010 / ESAC III Hospital Care Subproject Group. European Surveillance of Antibiotic Consumption (ESAC) point prevalence survey 2008: paediatric antimicrobial pres
Bronzwaer SL / 2001 / International surveillance of antimicrobial resistance in Europe: now we also need to monitor antibiotic use / Euro Surveill 6 : 1 ~ 2
Coenen S / 2006 / European Surveillance of Antimicrobial Consumption (ESAC): outpatient cephalosporin use in Europe / J Antimicrob Chemother 58 : 413 ~ 417
이 논문의 저자 정보
최근 본 자료
댓글(0)
0